SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
The FBI untangled the mysterious Jan. 6, 2021, pipe bombs case by relying on a “new computer program,” which deciphered cellphone data that the agency had held for years. Earlier this month, the ...
Energy Transfer is one of the best-positioned companies to benefit from the artificial intelligence (AI) boom and the industry's voracious need for power. It owns one of the country's largest ...
FBI director suggests 'sheer incompetence' or 'negligence' in Biden admin handling of pipe bomb case
FBI Director Kash Patel on Thursday blasted the Biden administration for its handling of the investigation into who planted pipe bombs at the U.S. Capitol on Jan. 5, 2021. Patel told "Fox News @ Night ...
The quiet calm of a weekday morning in a Woodbridge, Virginia, neighborhood was suddenly interrupted Thursday by a loud siren, two Humvee-style vehicles and a group of SWAT-like figures in camouflage, ...
The FBI carefully analyzed the Jan. 6 pipe bomber suspect’s credit card purchases to isolate the components allegedly used to manufacture the two bombs, the newly filed criminal complaint obtained by ...
Loadings of crude oil from Chevron’s project in Kazakhstan continue at the CPC terminal at the Russian port of Novorossiysk on the Black Sea, the U.S. supermajor told Reuters after a Ukrainian attack ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Washington and Oregon governors ...
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of ...
- PIPE-307 treatment did not result in a significant change in binocular 2.5% low contrast letter acuity (LCLA) Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback